Cardiovascular consequences of sleep apnea

Lung

Volumn 190, Issue 2, 2012, Pages 113-132

  Golbidi, Saeid ^a   Badran, Mohammad ^a   Ayas, Najib ^a,b,c   Laher, Ismail ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Division of Critical Care Medicine   (Canada)

Author keywords

Animal models; Cardiovascular; Intermittent hypoxia; Metabolic dysregulation; Sleep apnea

Indexed keywords

ADRENERGIC STIMULATION; AIRWAY OBSTRUCTION; CARDIOVASCULAR DISEASE; ENDOTHELIAL DYSFUNCTION; EXPERIMENTAL STUDY; HUMAN; HYPERCOAGULABILITY; INFLAMMATION; INTERMITTENT HYPOXIA; METABOLIC SYNDROME X; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SLEEP APNEA SYNDROME;

ANIMALS; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; ENDOTHELIUM; HUMANS; INFLAMMATION; METABOLIC SYNDROME X; OXIDATIVE STRESS; SLEEP APNEA SYNDROMES; SLEEP DISORDERS, INTRINSIC; THROMBOPHILIA;

EID: 84863468852     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-011-9340-1     Document Type: Review

References (185)

1. Gupta RK, Chandra A, Verm AK, Kumar S (2010) Obstructive sleep apnoea: a clinical review. J Assoc Physicians India 58:438-441
2. Dempsey JA, Veasey SC, Morgan BJ, O'Donnell CP (2010) Pathophysiology of sleep apnea. Physiol Rev 90:47-112
3. Partinen M (1995) Epidemiology of obstructive sleep apnea syndrome. Curr Opin Pulm Med 1:482-487
4. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230-1235 (Pubitemid 23115702)
5. Lavie L, Lavie P (2009) Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 33:1467-1484
6. Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378-1384 (Pubitemid 30262394)
7. Kanagy NL (2009) Vascular effects of intermittent hypoxia. ILAR J 50:282-288
8. Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi-Filho G (2005) Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172:613-618 (Pubitemid 41232973)
9. Itzhaki S, Lavie L, Pillar G, Tal G, Lavie P (2005) Endothelial dysfunction in obstructive sleep apnea measured by peripheral arterial tone response in the finger to reactive hyperemia. Sleep 28:594-600 (Pubitemid 40677373)
10. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 52:686-717
11. Golbidi S, Laher I (2010) Antioxidant therapy in human endocrine disorders. Med Sci Monit 16: RA9-RA24
12. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W, Grimminger F (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162:566-570 (Pubitemid 30647201)
13. Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165:934-939 (Pubitemid 34774660)
14. Barceló A, Miralles C, Barbé F, Vila M, Pons S, Agustí AG (2000) Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 16:644-647
15. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ (2003) 8-Isoprostane, a marker of oxi-dative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124:1386-1392 (Pubitemid 37290049)
16. Christou K, Moulas AN, Pastaka C, Gourgoulianis KI (2003) Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 4:225-228 (Pubitemid 36748608)
17. Chen L, Einbinder E, Zhang Q, Hasday J, Balke CW, Scharf SM (2005) Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. Am J Respir Crit Care Med 172:915-920 (Pubitemid 41369077)
18. Yamauchi M, Kimura H (2008) Oxidative stress in obstructive sleep apnea: putative pathways to the cardiovascular complications. Antioxid Redox Signal 10:755-768 (Pubitemid 351225902)
19. Williams A, Scharf SM (2007) Obstructive sleep apnea, cardiovascular disease, and inflammation is NFkappaB the key? Sleep Breath 11:69-76 (Pubitemid 46745858)
20. Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Tanaka A, Oda N, Okada S, Ohta S, Naito H, Adachi M (2005) Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172:625-630 (Pubitemid 41232975)
21. Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660-2667 (Pubitemid 41532603)
22. Greenberg H, Ye X, Wilson D, Htoo AK, Hendersen T, Liu SF (2006) Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem Biophys Res Commun 343:591-596
23. Takahashi S, Nakamura Y, Nishijima T, Sakurai S, Inoue H (2005) Essential roles of angiotensin II in vascular endothelial growth factor expression in sleep apnea syndrome. Respir Med 99:1125-1131 (Pubitemid 41102649)
24. Schulz R, Hummel C, Heinemann S, Seeger W, Grimminger F (2002) Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med 165:67-70 (Pubitemid 34053359)
25. Gjørup PH, Sadauskiene L, Wessels J, Nyvad O, Strunge B, Pedersen EB (2007) Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. Am J Hypertens 20:44-52 (Pubitemid 46014056)
26. Phillips SA, Olson EB, Morgan BJ, Lombard JH (2004) Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 286:H388-H393 (Pubitemid 38049504)
27. Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V, Somers VK (2000) Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102:2607-2610
28. Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC, Lam WK (2000) Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 162:2166-2171 (Pubitemid 32051681)
29. Chulz R, Schmidt D, Blum A, Lopes-Ribeiro X, Lucke C, Mayer K, Olschewski H, Seeger W, Grimminger F (2000) Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnea: response to CPAP therapy. Thorax 55:1046-1051
30. Lavie L, Hefetz A, Luboshitzky R, Lavie P (2003) Plasma levels of nitric oxide and L-arginine in sleep apnea patients: effects of nCPAP treatment. J Mol Neurosci 21:57-63 (Pubitemid 37204873)
31. Teramoto S, Kume H, Matsuse T, Ishii T, Miyashita A, Akishita M, Toba K, Ouchi Y (2003) Oxygen administration improves the serum level of nitric oxide metabolites in patients with obstructive sleep apnea syndrome. Sleep Med 4:403-407 (Pubitemid 37193023)
32. Bayram NA, Ciftci B, Keles T, Durmaz T, Turhan S, Bozkurt E, Peker Y (2009) Endothelial function in normotensive men with obstructive sleep apnea before and 6 months after CPAP treatment. Sleep 32:1257-1263
33. Schulz R, Seeger W, Grimminger F (2001) Serum nitrite/nitrate levels in obstructive sleep apnea. Am J Respir Crit Care Med 164:1997-1998 (Pubitemid 33152342)
34. Svatikova A, Wolk R, Wang HH, Otto ME, Bybee KA, Singh RJ, Somers VK (2004) Circulating free nitrotyrosine in obstructive sleep apnea. Am J Physiol 287:R284-R287 (Pubitemid 38970278)
35. Tabrizi-Fard MA, Maurer TS, Fung HL (1999) In vivo disposition of 3-nitro-L-tyrosine in rats: implications on tracking systemic peroxynitrite exposure. Drug Metab Dispos 27:429-431 (Pubitemid 29177632)
36. Jelic S, Padeletti M, Kawut SM, Higgins C, Canfield SM, Onat D, Colombo PC, Basner RC, Factor P, LeJemtel TH (2008) Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 117:2270-2278
37. Tanaka T, Nakamura H, Yodoi J, Bloom ET (2005) Redox regulation of the signaling pathways leading to eNOS phos-phorylation. Free Radic Biol Med 38:1231-1242 (Pubitemid 40445540)
38. Yung LM, Leung FP, Yao X, Chen ZY, Huang Y (2006) Reactive oxygen species in vascular wall. Cardiovasc Hematol Disord Drug Targets 6:1-19 (Pubitemid 43803123)
39. Antoniades C, Shirodaria C, Warrick N, Cai S, de Bono J, Lee J, Leeson P, Neubauer S, Ratnatunga C, Pillai R, Refsum H, Channon KM (2006) 5-Methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 114:1193-1201 (Pubitemid 44386484)
40. Carlson J, Hedner J, Pettersson A (1997) Increased plasma concentration of ADMA, a naturally occurring nitric oxide synthesis inhibitor, in OSA patients. Am J Respir Crit Care Med 155:A869
41. Ohike Y, Kozaki K, Iijima K, Eto M, Kojima T, Ohga E, Santa T, Imai K, Hashimoto M, Yoshizumi M, Ouchi Y (2005) Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure-possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 69:221-226 (Pubitemid 40313045)
42. Bolli R, Shinmura K, Tang XL, Kodani E, Xuan YT, Guo Y, Dawn B (2002) Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. Cardiovasc Res 55:506-519 (Pubitemid 34874945)
43. Antman EM, DeMets D, Loscalzo J (2005) Cyclooxygenase inhibition and cardiovascular risk. Circulation 112:759-770 (Pubitemid 41099056)
44. Lefebvre B, Godin-Ribuot D, Joyeux-Faure M, Caron F, Bes-sard G, Lévy P, Stanke-Labesque F (2006) Functional assessment of vascular reactivity after chronic intermittent hypoxia in the rat. Respir Physiol Neurobiol 150:278-286 (Pubitemid 43227466)
45. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, Somers VK (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105:2462-2464 (Pubitemid 34568964)
46. Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y (2003) Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94:179-184 (Pubitemid 36014310)
47. Lavie L, Polotsky V (2009) Cardiovascular aspects in obstructive sleep apnea syndrome-molecular issues, hypoxia and cytokine profiles. Respiration 78:361-370
48. Zamarron C, García Paz V, Riveiro A (2008) Obstructive sleep apnea syndrome is a systemic disease. Current evidence. Eur J Intern Med 19:390-398
49. Hoffstein V, Herridge M, Mateika S, Redline S, Strohl KP (1994) Hematocrit levels in sleep apnea. Chest 106:787-791 (Pubitemid 24278885)
50. Nobili L, Schiavi G, Bozano E, De Carli F, Ferrillo F, Nobili F (2000) Morning increase of whole blood viscosity in obstructive sleep apnea syndrome. Clin Hemorheol Microcirc 22:21-27 (Pubitemid 30139722)
51. Geiser T, Buck F, Meyer BJ, Bassetti C, Haeberli A, Gugger M (2002) In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 69:229-234 (Pubitemid 34827837)
52. Hui DS, Ko FW, Fok JP, Chan MC, Li TS, Tomlinson B, Cheng G (2004) The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest 125:1768-1775 (Pubitemid 38648410)
53. Wessendorf TE, Thilmann AF, Wang YM, Schreiber A, Kon-ietzko N, Teschler H (2000) Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med 162:2039-2042 (Pubitemid 32051660)
54. Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR (2004) Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 59:777-782 (Pubitemid 39215375)
55. Zamarron C, Ricoy J, Riveiro A, Gude F (2008) Plasminogen activator inhibitor-1 in obstructive sleep apnea patients with and without hypertension. Lung 186:151-156
56. von Känel R, Loredo JS, Ancoli-Israel S, Mills PJ, Natarajan L, Dimsdale JE (2007) Association between polysomnographic measures of disrupted sleep and prothrombotic factors. Chest 131:733-739 (Pubitemid 46446864)
57. Dimova EY, Samoylenko A, Kietzmann T (2004) Oxidative stress and hypoxia: implications for plasminogen activator inhibitor-1 expression. Antioxid Redox Signal 6:777-791 (Pubitemid 38890795)
58. von Känel R, Dimsdale JE (2003) Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest 124:1956-1967 (Pubitemid 37433597)
59. Guyenet PG (2006) The sympathetic control of blood pressure. Nat Rev Neurosci 7:335-346
60. Leung RS, Bradley TD (2001) Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 164:2147-2165 (Pubitemid 34032928)
61. Brooks D, Horner RL, Floras JS, Kozar LF, Render-Teixeira CL, Phillipson EA (1999) Baroreflex control of heart rate in a canine model of obstructive sleep apnea. Am J Respir Crit Care Med 159:1293-1297 (Pubitemid 29202570)
62. Tkacova R, Dajani HR, Rankin F, Fitzgerald FS, Floras JS, Douglas Bradley T (2000) Continuous positive airway pressure improves nocturnal baroreflex sensitivity of patients with heart failure and obstructive sleep apnea. J Hypertens 18:1257-1262
63. Peng YJ, Overholt JL, Kline D, Kumar GK, Prabhakar NR (2003) Induction of sensory long-term facilitation in the carotid body by intermittent hypoxia: implications for recurrent apneas. Proc Natl Acad Sci USA 100:10073-10078 (Pubitemid 37087069)
64. Dematteis M, Godin-Ribuot D, Arnaud C, Ribuot C, Stanke-Labesque F, Pépin JL, Lévy P (2009) Cardiovascular consequences of sleep-disordered breathing: contribution of animal models to understanding the human disease. ILAR J 50:262-281
65. Dematteis M, Julien C, Guillermet C, Sturm N, Lantuejoul S, Mallaret M, Lévy P, Gozal E (2008) Intermittent hypoxia induces early functional cardiovascular remodeling in mice. Am J Respir Crit Care Med 177:227-235
66. Kohler M, Stradling JR (2010) Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 7:677-685
67. Cutler MJ, Swift NM, Keller DM, Wasmund WL, Burk JR, Smith ML (2004) Periods of intermittent hypoxic apnea can alter chemoreflex control of sympathetic nerve activity in humans. Am J Physiol Heart Circ Physiol 287:H2054-H2060 (Pubitemid 39430744)
68. Lai CJ, Yang CC, Hsu YY, Lin YN, Kuo TB (2006) Enhanced sympathetic outflow and decreased baroreflex sensitivity are associated with intermittent hypoxia-induced systemic hypertension in conscious rats. J Appl Physiol 100:1974-1982 (Pubitemid 43845873)
69. Fletcher EC, Orolinova N, Bader M (2002) Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J Appl Physiol 92:627-633 (Pubitemid 34671030)
70. Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897-1904
71. Fletcher EC, Miller J, Schaaf JW, Fletcher JG (1987) Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 10:35-44
72. Kohler M, Pepperell JC, Casadei B, Craig S, Crosthwaite N, Stradling JR, Davies RJ (2008) CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J 32:1488-1496
73. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF (2007) Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176:706-712 (Pubitemid 47503079)
74. Ziegler MG, Mills PJ, Loredo JS, Ancoli-Israel S, Dimsdale JE (2001) Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest 120:887-893 (Pubitemid 32885465)
75. Mills PJ, Kennedy BP, Loredo JS, Dimsdale JE, Ziegler MG (2006) Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea. J Appl Physiol 100:343-348 (Pubitemid 43671127)
76. Norman D, Loredo JS, Nelesen RA, Ancoli-Israel S, Mills PJ, Ziegler MG, Dimsdale JE (2006) Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 47:840-845 (Pubitemid 44297553)
77. Leiter JC, Knuth SL, Bartlett D Jr (1985) The effect of sleep deprivation on activity of the genioglossus muscle. Am Rev Respir Dis 132:1242-1245 (Pubitemid 16156380)
78. Cooper KR, Phillips BA (1982) Effect of short-term sleep loss on breathing. J Appl Physiol 53:855-858 (Pubitemid 12000775)
79. White DP, Douglas NJ, Pickett CK, Zwillich CW, Weil JV (1983) Sleep deprivation and the control of ventilation. Am Rev Respir Dis 128:984-986 (Pubitemid 14207090)
80. Tartar JL, Ward CP, Cordeira JW, Legare SL, Blanchette AJ, McCarley RW, Strecker RE (2008) Experimental sleep fragmentation and sleep deprivation in rats increases exploration in an open field test of anxiety while increasing plasma cortico-sterone levels. Behav Brain Res 197:450-453
81. Andersen ML, Martins PJF, D'Almeida V, Bignotto M, Tufik S (2005) Endocrinological and catecholaminergic alterations during sleep deprivation and recovery in male rats. J Sleep Res 14:83-90 (Pubitemid 40403059)
82. Andersen ML, Martins PJF, D'Almeida V, Santos RF, Bignotto M, Tufik S (2004) Effects of paradoxical sleep deprivation on blood parameters associated with cardiovascular risk in aged rats. Exp Gerontol 39:817-824 (Pubitemid 38586822)
83. Everson CA, Crowley WR (2004) Reductions in circulating anabolic hormones induced by sustained sleep deprivation in rats. Am J Physiol Endocrinol Metab 286:E1060-E1070 (Pubitemid 38668831)
84. Perry JC, D'Almeida V, Souza FG, Schoorlemmer GH, Co-lombari E, Tufik S (2007) Consequences of subchronic and chronic exposure to intermittent hypoxia and sleep deprivation on cardiovascular risk factors in rats. Respir Physiol Neurobiol 156:250-258 (Pubitemid 46436597)
85. Yehuda S, Sredni B, Carrasso RL, Kenigsbuch-Sredni D (2009) REM sleep deprivation in rats results in inflammation and interleukin-17 elevation. J Interferon Cytokine Res 29:393-398
86. Irwin MR, Wang M, Ribeiro D, Cho HJ, Olmstead R, Breen EC, Martinez-Maza O, Cole S (2008) Sleep loss activates cellular inflammatory signaling. Biol Psychiatry 64:538-540
87. Van Dongen HP, Maislin G, Mullington JM, Dinges DF (2003) The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 26:117-126 (Pubitemid 39610686)
88. Haack M, Mullington JM (2005) Sustained sleep restriction reduces emotional and physical well-being. Pain 119:56-64 (Pubitemid 41752965)
89. Nair D, Zhang SX, Ramesh V, Hakim F, Kaushal N, Wang Y, Gozal D (2011) Sleep fragmentation induces cognitive deficits via NADPH oxidase-dependent pathways in mouse. Am J Respir Crit Care Med. doi:10.1164/rccm.201107-1173OC
90. Li J, Thorne LN, Punjabi NM, Sun CK, Schwartz AR, Smith PL, Marino RL, Rodriguez A, Hubbard WC, O'Donnell CP, Polot-sky VY (2005) Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 97:698-706 (Pubitemid 41416339)
91. Li J, Savransky V, Nanayakkara A, Smith PL, O'Donnell CP, Polotsky VY (2007) Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol 102:557-563 (Pubitemid 46220883)
92. Savransky V, Jun. J, Li J, Nanayakkara A, Fonti S, Moser AB, Steele KE, Schweitzer MA, Patil SP, Bhanot S, Schwartz AR, Polotsky VY (2008) Dyslipidemia and atherosclerosis induced by chronic intermittent hypoxia are attenuated by deficiency of stearoyl coenzyme A desaturase. Circ Res 103:1173-1180
93. Drager LF, Jun. JC, Polotsky VY (2010) Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea. Best Pract Res Clin Endocrinol Metab 24:843-851
94. Savransky V, Nanayakkara A, Vivero A, Li J, Bevans S, Smith PL, Torbenson MS, Polotsky VY (2007) Chronic intermittent hypoxia predisposes to liver injury. Hepatology 45:1007-1013 (Pubitemid 46631569)
95. Pamidi S, Aronsohn RS, Tasali E (2010) Obstructive sleep apnea: role in the risk and severity of diabetes. Best Pract Res Clin Endocrinol Metab 24:703-715
96. Farré R, Montserrat JM, Navajas D (2008) Morbidity due to obstructive sleep apnea: insights from animal models. Curr Opin Pulm Med 14:530-536
97. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL (2002) Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677-682 (Pubitemid 34194756)
98. Punjabi NM, Beamer BA (2009) Alterations in glucose disposal in sleep-disordered breathing. Am J Respir Crit Care Med 179:235-240
99. Iiyori N, Alonso LC, Li J, Sanders MH, Garcia-Ocana A, O'Doherty RM, Polotsky VY, O'Donnell CP (2007) Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 175:851-857 (Pubitemid 46631798)
100. Polotsky VY, Li J, Punjabi NM, Rubin AE, Smith PL, Schwartz AR, O'Donnell CP (2003) Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 552:253-264 (Pubitemid 37265483)
101. Unger RH, Scherer PE (2010) Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol Metab 21:345-352
102. Magalang UJ, Cruff JP, Rajappan R, Hunter MG, Patel T, Marsh CB, Raman SV, Parinandi NL (2009) Intermittent hypoxia suppresses adiponectin secretion by adipocytes. Exp Clin Endocrinol Diabetes 117:129-134
103. Jun. J, Polotsky VY (2007) Sleep disordered breathing and metabolic effects: evidence from animal models. Sleep Med Clin 2:263-277
104. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11:183-190 (Pubitemid 40321354)
105. Parlapiano C, Borgia MC, Minni A, Alessandri N, Basal I, Sa-ponara M (2005) Cortisol circadian rhythm and 24-hour Holter arterial pressure in OSAS patients. Endocr Res 31:371-374 (Pubitemid 43207231)
106. Wang TY, Chen XQ, Du JZ, Xu NY, Wei CB, Vale WW (2004) Corticotropin-releasing factor receptor type 1 and 2 mRNA expression in the rat anterior pituitary is modulated by intermittent hypoxia, cold and restraint. Neuroscience 128:111-119 (Pubitemid 39140684)
107. Neuzeret PC, Gormand F, Reix P, Parrot S, Sastre JP, Buda C, Guidon G, Sakai K, Lin JS (2011) A new animal model of obstructive sleep apnea responding to continuous positive airway pressure. Sleep 34:541-548
108. Hendricks JC, Kline LR, Kovalski RJ, O'Brien JA, Morrison AR, Pack AI (1987) The English bulldog: a natural model of sleep-disordered breathing. J Appl Physiol 63:1344-1350 (Pubitemid 18024166)
109. Veasey SC, Fenik P, Panckeri K, Pack AI, Hendricks JC (1999) The effects of trazodone with L-tryptophan on sleep-disordered breathing in the English bulldog. Am J Respir Crit Care Med 160:1659-1667
110. Veasey SC, Chachkes J, Fenik P, Hendricks JC (2001) The effects of ondansetron on sleep-disordered breathing in the English bulldog. Sleep 24:155-160 (Pubitemid 32204191)
111. Carley DW, Radulovacki M (2003) Sleep-related breathing disorders, experimental models and therapeutic potential. Marcel Dekker, New York
112. Lonergan RP 3rd, Ware JC, Atkinson RL, Winter WC, Suratt PM (1998) Sleep apnea in obese miniature pigs. J Appl Physiol 84:531-536 (Pubitemid 28081105)
113. Tuck SA, Dort JC, Olson ME, Remmers JE (1999) Monitoring respiratory function and sleep in the obese Vietnamese potbellied pig. J Appl Physiol 87:444-451 (Pubitemid 29330712)
114. Philip P, Gross CE, Taillard J, Bioulac B, Guilleminault C (2005) An animal model of a spontaneously reversible obstructive sleep apnea syndrome in the monkey. Neurobiol Dis 20:428-431 (Pubitemid 41476268)
115. Van Lunteren E (1996) Effects of genetic obesity on rat upper airway muscle and diaphragm contractile properties. Eur Respir J 9:2139-2144 (Pubitemid 26333557)
116. Alonso-Galicia M, Brands MW, Zappe DH, Hall JE (1996) Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity. Hypertension 28:1047-1054 (Pubitemid 26415823)
117. Fredersdorf S, Thumann C, Ulucan C, Griese DP, Luchner A, Riegger GA, Kromer EP, Weil J (2004) Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats. Cardiovasc Pathol 13:11-19 (Pubitemid 38169461)
118. Lee SD, Nakano H, Farkas GA (2005) Adenosinergic modulation of ventilation in obese Zucker rats. Obes Res 13:545-555
119. Radulovacki M, Trbovic S, Carley DW (1996) Hypotension reduces sleep apneas in Zucker lean and Zucker obese rats. Sleep 19:767-773 (Pubitemid 27131926)
120. Nakano H, Magalang UJ, Lee SD, Krasney JA, Farkas GA (2001) Serotonergic modulation of ventilation and upper airway stability in obese Zucker rats. Am J Respir Crit Care Med 163:1191-1197 (Pubitemid 32378459)
121. Brennick MJ, Pickup S, Cater JR, Kuna ST (2006) Phasic respiratory pharyngeal mechanics by magnetic resonance imaging in lean and obese Zucker rats. Am J Respir Crit Care Med 173:1031-1037
122. Lee SD, Kuo WW, Bau DT, Ko FY, Wu FL, Kuo CH, Tsai FJ, Wang PS, Lu MC, Huang CY (2008) The coexistence of nocturnal sustained hypoxia and obesity additively increases cardiac apoptosis. J Appl Physiol 104:1144-1153 (Pubitemid 351507956)
123. Wajant H (2002) The Fas signaling pathway: more than a paradigm. Science 296:1635-1636 (Pubitemid 34579146)
124. Schneider P, Bodmer JL, Holler N, Mattmann C, Scuderi P, Terskikh A, Peitsch MC, Tschopp J (1997) Characterization of Fas (Apo-1, CD95)-Fas ligand interaction. J Biol Chem 272:18827-18833 (Pubitemid 27318231)
125. Sato T, Saito H, Seto K, Takatsuji H (1990) Sleep apneas and cardiac arrhythmias in freely moving rats. Am J Physiol 259:R282-R287 (Pubitemid 20259461)
126. Mendelson WB, Martin JV, Perlis M, Giesen H, Wagner R, Rapoport SI (1988) Periodic cessation of respiratory effort during sleep in adult rats. Physiol Behav 43:229-234
127. Thomas AJ, Austin W, Friedman L, Strohl KP (1992) A model of ventilatory instability induced in the unrestrained rat. J Appl Physiol 73:1530-1536
128. Carley DW, Trbovic S, Radulovacki M (1996) Sleep apnea in normal and REM sleep-deprived normotensive Wistar-Kyoto and spontaneously hypertensive (SHR) rats. Physiol Behav 59:827-831 (Pubitemid 26110705)
129. Kuo TB, Lai CJ, Shaw FZ, Lai CW, Yang CC (2004) Sleep-related sympathovagal imbalance in SHR. Am J Physiol 286:H1170-H1176 (Pubitemid 38248634)
130. Plante GE (2006) Sleep and vascular disorders. Metabolism 55:s45-s49 (Pubitemid 44353571)
131. Carley DW, Berecek K, Videnovic A, Radulovacki M (2000) Sleep-disordered respiration in phenotypically normotensive, genetically hypertensive rats. Am J Respir Crit Care Med 162:1474-1479
132. Carley DW, Trbovic SM, Bozanich A, Radulovacki M (1997) Cardiopulmonary control in sleeping Sprague-Dawley rats treated with hydralazine. J Appl Physiol 83:1954-1961 (Pubitemid 28006496)
133. Trbovic SM, Radulovacki M, Carley DW (1997) Protoveratrines A and B increase sleep apnea index in Sprague-Dawley rats. J Appl Physiol 83:1602-1606 (Pubitemid 27495337)
134. Carley DW, Radulovacki M (1999) Mirtazapine, a mixed-profile serotonin agonist/antagonist, suppresses sleep apnea in the rat. Am J Respir Crit Care Med 160:1824-1829 (Pubitemid 30004682)
135. Carley DW, Olopade C, Ruigt GS, Radulovacki M (2007) Efficacy of mirtazapine in obstructive sleep apnea syndrome. Sleep 30:35-41 (Pubitemid 46095381)
136. Peters LL, Robledo RF, Bult CJ, Churchill GA, Paigen BJ, Svenson KL (2007) The mouse as a model for human biology: a resource guide for complex trait analysis. Nat Rev Genet 8:58-69 (Pubitemid 46006050)
137. Nakamura A, Kuwaki T (2003) Sleep apnea in mice: a useful animal model for study of SIDS? Early Hum Dev 75:S167-S174 (Pubitemid 39658670)
138. Yamauchi M, Kimura H, Strohl KP (2010) Mouse models of apnea: strain differences in apnea expression and its pharmaco-logic and genetic modification. Adv Exp Med Biol 669:303-307
139. Berry-Kravis EM, Zhou L, Rand CM, Weese-Mayer DE (2006) Congenital central hypoventilation syndrome: PHOX2B mutations and phenotype. Am J Respir Crit Care Med 174:1139-1144 (Pubitemid 44772085)
140. Burton MD, Kawashima A, Brayer JA, Kazemi H, Shannon DC, Schuchardt A, Costantini F, Pachnis V, Kinane TB (1997) RET proto-oncogene is important for the development of respiratory CO2 sensitivity. J Auton Nerv Syst 63:137-143 (Pubitemid 27168873)
141. Tsujino N, Sakurai T (2009) Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev 61:162-176
142. Nakamura A, Zhang W, Yanagisawa M, Fukuda Y, Kuwaki T (2007) Vigilance state-dependent attenuation of hypercapnic chemoreflex and exaggerated sleep apnea in orexin knockout mice. J Appl Physiol 102:241-248 (Pubitemid 46089772)
143. Baekey DM, Feng P, Decker MJ, Strohl KP (2009) Breathing and sleep: measurement methods, genetic influences, and developmental impacts. ILAR J 50:248-261
144. Brennick MJ, Pack AI, Ko K, Kim E, Pickup S, Maislin G, Schwab RJ (2009) Altered upper airway and soft tissue structures in the New Zealand Obese mouse. Am J Respir Crit Care Med 179:158-169
145. Brennick MJ, Kuna ST, Pickup S, Cater J, Schwab RJ (2011) Respiratory modulation of the pharyngeal airway in lean and obese mice. Respir Physiol Neurobiol 175:296-302
146. Katayama K, Smith CA, Henderson KS, Dempsey JA (2007) Chronic intermittent hypoxia increases the CO2 reserve in sleeping dogs. J Appl Physiol 103:1942-1949 (Pubitemid 350232375)
147. Kimoff RJ, Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Champagne V, Mayer P, Phillipson EA (1997) Ventilatory and arousal responses to hypoxia and hypercapnia in a canine model of obstructive sleep apnea. Am J Respir Crit Care Med 156:886-894 (Pubitemid 27396431)
148. Launois SH, Averill N, Abraham JH, Kirby DA, Weiss JW (2001) Cardiovascular responses to nonrespiratory and respiratory arousals in a porcine model. J Appl Physiol 90:114-120 (Pubitemid 32038510)
149. White SG, Fletcher EC, Miller CC 3rd (1995) Acute systemic blood pressure elevation in obstructive and nonobstructive breath hold in primates. J Appl Physiol 79:324-330
150. Farré R, Rotger M, Montserrat JM, Calero G, Navajas D (2003) Collapsible upper airway segment to study the obstructive sleep apnea/hypopnea syndrome in rats. Respir Physiol Neurobiol 136:199-209 (Pubitemid 36809007)
151. Nácher M, Serrano-Mollar A, Farré R, Panés J, Seguí J, Montserrat JM (2007) Recurrent obstructive apneas trigger early systemic inflammation in a rat model of sleep apnea. Respir Physiol Neurobiol 155:93-96 (Pubitemid 46049132)
152. Schneider H, Schaub CD, Chen CA, Andreoni KA, Schwartz AR, Smith PL, Robotham JL, O'Donnell CP (2000) Effects of arousal and sleep state on systemic and pulmonary hemody-namics in obstructive apnea. J Appl Physiol 88:1084-1092 (Pubitemid 30154915)
153. Schoorlemmer GH, Rossi MV, Tufik S, Cravo SL (2011) A new method to produce obstructive sleep apnoea in conscious unrestrained rats. Exp Physiol 96:1010-1018
154. Farré R, Nácher M, Serrano-Mollar A, Gáldiz JB, Alvarez FJ, Navajas D, Montserrat JM (2007) Rat model of chronic recurrent airway obstructions to study the sleep apnea syndrome. Sleep 30:930-933 (Pubitemid 47041397)
155. Hamrahi H, Stephenson R, Mahamed S, Liao KS, Horner RL (2001) Selected Contribution: Regulation of sleep-wake states in response to intermittent hypoxic stimuli applied only in sleep. J Appl Physiol 90:2490-2501
156. Bonsignore MR, Marrone O, Insalaco G, Bonsignore G (1994) The cardiovascular effects of obstructive sleep apnoeas: analysis of pathogenic mechanisms. Eur Respir J 7:786-805 (Pubitemid 24122978)
157. McGuire M, Bradford A (2001) Chronic intermittent hyper-capnic hypoxia increases pulmonary arterial pressure and hae-matocrit in rats. Eur Respir J 18:279-285 (Pubitemid 32776402)
158. de Frutos S, Duling L, Alò D, Berry T, Jackson-Weaver O, Walker M, Kanagy N, González Bosc L (2008) NFATc3 is required for intermittent hypoxia-induced hypertension. Am J Physiol Heart Circ Physiol 294:H2382-H2390
159. Dunleavy M, Dooley M, Cox D, Bradford A (2005) Chronic intermittent asphyxia increases platelet reactivity in rats. Exp Physiol 90:411-416 (Pubitemid 40685855)
160. Carreras A, Wang Y, Gozal D, Montserrat JM, Navajas D, Farré R (2011) Non-invasive system for applying airway obstructions to model obstructive sleep apnea in mice. Respir Physiol Neurobiol 175:164-168
161. Lesske J, Fletcher EC, Bao G, Unger T (1997) Hypertension caused by chronic intermittent hypoxia-influence of chemoreceptors and sympathetic nervous system. J Hypertens 15:1593-1603 (Pubitemid 28029653)
162. Bradford A (2004) Effects of chronic intermittent asphyxia on haematocrit, pulmonary arterial pressure and skeletal muscle structure in rats. Exp Physiol 89:44-52 (Pubitemid 38128851)
163. Allahdadi KJ, Walker BR, Kanagy NL (2005) Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 45:705-709 (Pubitemid 40418369)
164. Fletcher EC (2001) Invited review: Physiological consequences of intermittent hypoxia: systemic blood pressure. J Appl Physiol 90:1600-1605
165. Kanagy NL, Walker BR, Nelin LD (2001) Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 37:511-515 (Pubitemid 32199020)
166. Julien C, Bayat S, Lévy P (2003) Vascular reactivity to nor-epinephrine and acetylcholine after chronic intermittent hypoxia in mice. Respir Physiol Neurobiol 139:21-32 (Pubitemid 37443619)
167. Tahawi Z, Orolinova N, Joshua IG, Bader M, Fletcher EC (2001) Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats. J Appl Physiol 90:2007-2013
168. McNulty PH, Ng C, Liu WX, Jagasia D, Letsou GV, Baldwin JC, Soufer R (1996) Autoregulation of myocardial glycogen concentration during intermittent hypoxia. Am J Physiol 271:R311-R319
169. Li J, Grigoryev DN, Ye SQ, Thorne L, Schwartz AR, Smith PL, O'Donnell CP, Polotsky VY (2005) Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J Appl Physiol 99:1643-1648 (Pubitemid 41547158)
170. Li J, Bosch-Marce M, Nanayakkara A, Savransky V, Fried SK, Semenza GL, Polotsky VY (2006) Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha. Physiol Genomics 25:450-457 (Pubitemid 43764766)
171. Li J, Nanayakkara A, Jun. J, Savransky V, Polotsky VY (2007) Effect of deficiency in SREBP cleavage-activating protein on lipid metabolism during intermittent hypoxia. Physiol Genomics 31:237-280
172. Feng SZ, Tian JL, Zhang Q, Wang H, Sun N, Zhang Y, Chen BY (2011) An experimental research on chronic intermittent hypoxia leading to liver injury. Sleep Breath 15:493-502
173. Liu JN, Zhang JX, Lu G, Qiu Y, Yang D, Yin GY, Zhang XL (2010) The effect of oxidative stress in myocardial cell injury in mice exposed to chronic intermittent hypoxia. Chin Med J (Engl) 123:74-78
174. Matsumoto C, Hayashi T, Kitada K, Yamashita C, Miyamura M, Mori T, Ukimura A, Ohkita M, Jin D, Takai S, Miyazaki M, Okada Y, Kitaura Y, Matsumura Y (2009) Chymase plays an important role in left ventricular remodeling induced by intermittent hypoxia in mice. Hypertension 54:164-171
175. Nácher M, Farré R, Montserrat JM, Torres M, Navajas D, Bulbena O, Serrano-Mollar A (2009) Biological consequences of oxygen desaturation and respiratory effort in an acute animal model of obstructive sleep apnea (OSA). Sleep Med 10:892-897
176. Savransky V, Bevans S, Nanayakkara A, Li J, Smith PL, Tor-benson MS, Polotsky VY (2007) Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol 293:G871-G877 (Pubitemid 47605939)
177. Troncoso Brindeiro CM, da Silva AQ, Allahdadi KJ, Young-blood V, Kanagy NL (2007) Reactive oxygen species contribute to sleep apnea-induced hypertension in rats. Am J Physiol Heart Circ Physiol 293:H2971-H2976 (Pubitemid 350106521)
178. Park AM, Suzuki YJ (2007) Effects of intermittent hypoxia on oxidative stress-induced myocardial damage in mice. J Appl Physiol 102:1806-1814 (Pubitemid 46701948)
179. Rosa DP, Martinez D, Picada JN, Semedo JG, Marroni NP (2011) Hepatic oxidative stress in an animal model of sleep apnoea: effects of different duration of exposure. Comp Hepatol 10:1
180. Xu W, Chi L, Row BW, Xu R, Ke Y, Xu B, Luo C, Kheirandish L, Gozal D, Liu R (2004) Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neu-ronal cell apoptosis in a mouse model of sleep apnea. Neuro-science 126:313-323 (Pubitemid 38780807)
181. Allahdadi KJ, Cherng TW, Pai H, Silva AQ, Walker BR, Nelin LD, Kanagy NL (2008) Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia. Am J Physiol Heart Circ Physiol 295:H434-H440
182. Knight WD, Little JT, Carreno FR, Toney GM, Mifflin SW, Cunningham JT (2011) Chronic intermittent hypoxia increases blood pressure and expression of FosB/DeltaFosB in central autonomic regions. Am J Physiol Regul Integr Comp Physiol 301:R131-R139
183. Kalaria RN, Spoors L, Laude EA, Emery CJ, Thwaites-Bee D, Fairlie J, Oakley AE, Barer DH, Barer GR (2004) Hypoxia of sleep apnoea: cardiopulmonary and cerebral changes after intermittent hypoxia in rats. Respir Physiol Neurobiol 140:53-62 (Pubitemid 38510379)
184. Iturriaga R, Moya EA, Del Rio R (2010) Cardiorespiratory alterations induced by intermittent hypoxia in a rat model of sleep apnea. Adv Exp Med Biol 669:271-274
185. Othman M, Gordon SP, Iscoe S (2010) Repeated inspiratory occlusions in anesthetized rats acutely increases blood coagulability as assessed by thromboelastography. Respir Physiol Neurobiol 171:61-66